Clinical Trial Update: Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial results explore genomically guided radiation dose personalization for locally advanced non-small cell lung cancer, aiming to tailor radiation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II | EARLY_Phase 1 | Status: COMPLETED